Mesenchymal stem cell-based therapy and exosomes in COVID-19: current trends and prospects

M Abdelgawad, NS Bakry, AA Farghali… - Stem cell research & …, 2021 - Springer
Abstract Novel coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory
syndrome coronavirus-2. The virus causes an exaggerated immune response, resulting in a …

[HTML][HTML] Are mesenchymal stem cells able to manage cytokine storm in COVID-19 patients? A review of recent studies

NK Farkhad, H Reihani, AA Moghadam… - Regenerative …, 2021 - Elsevier
The Covid-19 disease has recently become one of the biggest challenges globally, and
there is still no specific medication. Findings showed the immune system in severe Covid-19 …

[HTML][HTML] Immunomodulatory effect of mesenchymal stem cells and mesenchymal stem-cell-derived exosomes for COVID-19 treatmen

K Jayaramayya, I Mahalaxmi, MD Subramaniam… - BMB …, 2020 - ncbi.nlm.nih.gov
The world has witnessed unimaginable damage from the coronavirus disease-19 (COVID-
19) pandemic. Because the pandemic is growing rapidly, it is important to consider diverse …

Mesenchymal stem cells and exosome therapy for COVID-19: current status and future perspective

A Gupta, S Kashte, M Gupta, HC Rodriguez… - Human cell, 2020 - Springer
Acute respiratory distress syndrome (ARDS) is the main cause for the COVID-19 infection-
related morbidity and mortality. Recent clinical evidences suggest increased level of …

Therapeutic potential of mesenchymal stem cells and their exosomes in severe novel coronavirus disease 2019 (COVID-19) cases

A Tsuchiya, S Takeuchi, T Iwasawa, M Kumagai… - Inflammation and …, 2020 - Springer
The novel coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is
the causative agent of coronavirus disease 2019 (COVID-19) and the ensuing worldwide …

The potential use of mesenchymal stem cells and their derived exosomes as immunomodulatory agents for COVID‐19 patients

FA Alzahrani, IM Saadeldin, A Ahmad… - Stem cells …, 2020 - Wiley Online Library
A novel severe acute respiratory syndrome coronavirus (SARS‐CoV‐2) causing lethal acute
respiratory disease emerged in December 2019. The World Health Organization named this …

Mesenchymal stem cell alongside exosomes as a novel cell-based therapy for COVID-19: A review study

M Dauletova, H Hafsan, N Mahhengam, AO Zekiy… - Clinical …, 2021 - Elsevier
In the past year, an emerging disease called Coronavirus disease 2019 (COVID-19), caused
by Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been discovered in …

Mesenchymal stem cells and their derived exosomes to combat Covid–19

M Yousefi Dehbidi, N Goodarzi… - Reviews in Medical …, 2022 - Wiley Online Library
Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is causing an ongoing
pandemic of coronavirus disease 2019 (Covid‐19). Effective therapies are required for the …

Proposed mechanisms of targeting COVID-19 by delivering mesenchymal stem cells and their exosomes to damaged organs

E Jamshidi, A Babajani, P Soltani… - Stem Cell Reviews and …, 2021 - Springer
With the outbreak of coronavirus disease (COVID-19) caused by novel severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), the world has been facing an …

Allogenic mesenchymal stromal cells and their extracellular vesicles in COVID-19 induced ARDS: a randomized controlled trial

M Zarrabi, MA Shahrbaf, M Nouri, F Shekari… - Stem Cell Research & …, 2023 - Springer
Background and aims The main causes of death in patients with severe Coronavirus
disease-2019 (COVID-19) are acute respiratory distress syndrome (ARDS) and multiorgan …